CTOs on the Move

MXISystems

www.mxisystems.com

 
MXISystems is a Fairview, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Blackrock Neurotech

Blackrock Neurotech builds implantable brain technology that changes lives. Our pioneering neuroscience tools push the boundaries of research and empower innovation across more than 500+ global institutional partners, restoring function in patients suffering from neurological disease (ALS, Alzheimer`s, Parkinson`s), dysfunction (epilepsy, pain, brain trauma), and paralysis disorders.

Strata Medical

Strata Medical, Inc. is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LivaNova

At LivaNova we strive to help where it really counts, where it truly matters the most. Where every single effort, of each one of us, is transformational and expected to leave a lasting mark. That is why at LivaNova we make each innovation count: global, accessible, relevant and breakthrough. Transforming medical innovation into meaningful solutions, into a sustainable healthcare system and ultimately into healthier and – importantly - better lives.

Union Supplier Of America Inc

Union Supplier Of America Inc is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GenMark Diagnostics

In 1993, a novel technology was invented by a team that included Jon Faiz Kayyem, PhD at The California Institute of Technology (CalTech). This invention combined nucleic acids and microelectronics to produce an electronic sensor for DNA detection. His invention was based on electrical detection of nucleic acids on a cassette based detection platform. Dr. Kayyem went on to found Clinical Micro Sensors, with the goal of translating this “eSensor” technology to disposable chips. Following several acquisitions of the technology, Dr. Kayyem became actively involved again in 2009, returning as an investor and then as CEO and Chairman of the Board. In 2009, a collaboration between Dr. Kayyem and Christopher Gleeson began. The two redefined the company strategy, and brought in a new board of directors, executive leadership team, and commercial management. In 2010, the company known at that time as Osmetech, was named GenMark Diagnostics and listed on NASDAQ. Mr. Gleeson remained an integral part of GenMark`s growth in the years that followed, serving as Chairman of the Board until his retirement in 2014. Dr. Kayyem currently serves as SVP, Research and Development.